About Us

Vitro Biopharma provides and continuously improves stem cells and related produducts and services according to applicable regulations.  The discovery of embryonic stem cells capable of differentiation into any cell type of the body was largely responsible for the development of modern stem cell technology.  Embryonic stem cells are also ethically contentious since, in certain cases, embryo destruction results from the use of embryonic stem cells.  However, adult stem cells are derived through non-destructive procedures from a variety of tissue sources.  Adult stem cells have been approved for clinical use for over 50 years and have a strong record of safety and efficacy for use in the treatment of numerous blood disorders and immunological conditions.  Presently, the MSC sector of stem cell research is one of the most rapidly growing and expanding fields within the entire stem cell industry.

Vitro Biopharma News

Vitro Biopharma 2019 CEO Shareholder Letter: Record Revenues Leading to Further Growth into 2020

Golden, Colorado—January 23, 2020—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its CEO letter to its shareholders including discussion of its 2019 results of operations ended October 31st 2019 and its expansion plans for 2020. Dear...

Vitro Biopharma Announces up to a $1,000,000 Private Offering of Series A Convertible Preferred and Warrants

Golden, Colorado – January 22, 2020-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma announced a private placement of Units consisting of Series A Convertible Preferred Stock (“Series A Preferred”), Class A Warrants and Class B Warrants. . The Company has...

Leading Denver-Based Orthopedic Surgeon to Join Vitro Biopharma’s Scientific Advisory Board

GOLDEN, CO / ACCESSWIRE / November 5, 2019 / Vitro Diagnostics, Inc. (OTCPK:VODG), dba Vitro Biopharma announced the appointment of Dr. In Sok Yi MD to its Scientific Advisory Board (SAB). Dr Yi is board certified in Orthopedic Surgery and Surgery of the Hand. He...

Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations

Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations Golden, Colorado-September 25th, 2019-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 3rd quarter ended September 24th 2019 financial results of operations....

Vitro Biopharma 2nd Quarter ended April 30th 2019 Financial Results of Operations

Golden, Colorado-June 19th, 2019-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 2nd quarter ended April 30th 2019 financial results of operations. Vitro Diagnostics Inc. (“Vitro Biopharma”) is pleased to announce a record 2nd quarter in Stem...

Vitro Biopharma Company Overview

The US-based Vitro Biopharma is focused on achieving the full potential of regenerative medicine. Established in 1986, Vitro Biopharma provides a unique mix of research and clinical products used by leading universities and institutions worldwide. Over the last 25...

Vitro Biopharma Receives ISO 13485 Certification Supporting its Stem Cell Medical Tourism Initiative

Golden, Colorado-April 30, 2019-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma one of the world’s emerging biotechnology companies focused on allogeneic Mesenchymal Stem Cell (“MSC”) research and clinical products including AlloRx Stem Cells™,  Brain Grow...

Vitro Biopharma Obtains CLIA Certification

Golden, Colorado—April 2, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of a Certificate of Compliance with CLIA (Clinical Laboratory Improvement Amendment) without deficiencies.  This allows Vitro Biopharma to perform clinical...

Vitro Biopharma 1st Quarter ended January 31st 2019 Financial Results of Operations

Golden, Colorado-March 21, 2018-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st 2019 financial results of operations.  Vitro Diagnostics Inc. (“Vitro Biopharma”) is pleased to announce a record 1st quarter in...

Vitro Biopharma Receives Approval for a Stem Cell Clinical Trial for Musculoskeletal Conditions by the Bahamas Ministry of Health

Golden, Colorado—March 12, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of provisional approval from the National Stem Cell Ethics Committee (NSCEC) of the Ministry of Health of the Commonwealth of the Bahamas for a clinical trial...

Our Products and Services

We are distinct from our competitors by a unique mix of proprietary formulations, technical know-how and patent-pending technology yielding substantial competitive advantages. Through our extensive commercial manufacturing experience, we are capable of highly efficient stem cell production yielding high margins for our clinical trial stem cell therapies.  We also manufacture our own MSC-Gro media for all cellular manufacturing yielding further cost savings and additional manufacturing efficiencies.

With rigorous control of all cell culture parameters our clinical grade stem cells are not only economical but exhibit potency advantages as well that optimize superior clinical performance. In addition to Best in Class stem cell products for transplantation, we have also developed stem cell activation products targeting adult stem cells.  This allows us to follow (or proceed) an adult stem cell transplant with further therapy to activate or differentiate stem cells to enhance and maximize the therapeutic benefit of a stem cell transplant.  Our CLIA-registered laboratory also provides biomarker profiling of the stem cells for the quantitation of stem cell status and measurement of therapeutic effects.

Cell Culture Media

We have developed several novel cell culture media formulations through over 25 years of research in this field.

Cell Lines

We provide human stem cell lines for use in research, drug discovery/development and pre-clinical studies.

Biomarker Profiling

Biomarker profiling plays an important role in drug discovery, diagnostics and molecular medicine.

Nutravivo-Dietary-Supplement

Activate Stem Cells to Migrate and Produce New Stem Cells. Find out all the benefits  it has to offer here!

“We are testing almost 10 kind of mediums from different makers. The result is that your MSC-GroTM is most powerful candidate among them.”

Beike Biotech, Inc.

Providing high quality commercialized cell lines, media, stem cell products & stem cell technology

Providing applications in stem cell research, drug discovery and STEM CELL therapies

Customer Service (303)-999-2130 Ext. 1

4621 Technology Drive Golden, CO 80403

Technical Support (303)-999-2130 Ext. 2

info@vitrobiopharma.com

Accounting (303)-999-2130 Ext. 3

Please click the image above to view our ISO 13485:2016.

Please click the image above to view our ISO 9001:2015 Certification.

Please click the image above to view our FDA registration.